FORMER OPENAI EXEC FIDJI SIMO DISCUSSES HER BATTLE WITH POTS AND HER STARTUP'S PLANS TO CURE IT WITH AI AND 3,500 VIALS OF BLOOD

Summary from the TLDR AI newsletter

Fidji Simo left OpenAI's leadership team after a seven-year battle with Postural Orthostatic Tachycardia Syndrome (POTS). Her new startup, ChronicleBio, will focus on using AI to cure POTS and other chronic diseases. The company has collected 153 terabytes of data from blood draws from people with chronic diseases so far. It plans to launch home blood draws to further increase its dataset. ChronicleBio plans to use the data to learn more about diseases and improve the success of clinical drug trials.